14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $33.24 $45.00 Tuesday, 23rd Apr 2024 CRBP stock ended at $37.74. This is 0.106% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 6.44% from a day low at $37.66 to a day high of $40.08.
90 days $7.44 $49.87
52 weeks $3.03 $49.87

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
Sep 22, 2020 $1.80 $1.80 $1.58 $1.64 5 396 987
Sep 21, 2020 $1.85 $1.86 $1.71 $1.72 4 601 899
Sep 18, 2020 $1.97 $1.98 $1.75 $1.90 32 952 985
Sep 17, 2020 $1.95 $1.99 $1.89 $1.96 2 260 510
Sep 16, 2020 $1.97 $2.02 $1.95 $1.97 3 236 848
Sep 15, 2020 $1.97 $2.08 $1.92 $1.97 4 681 322
Sep 14, 2020 $1.93 $2.00 $1.86 $1.93 4 863 977
Sep 11, 2020 $2.30 $2.30 $1.81 $1.88 14 209 607
Sep 10, 2020 $2.53 $2.54 $2.23 $2.27 8 730 536
Sep 09, 2020 $2.27 $2.56 $2.25 $2.44 14 281 875
Sep 08, 2020 $2.23 $2.45 $1.95 $2.23 47 066 463
Sep 04, 2020 $9.36 $9.60 $8.92 $9.25 1 909 056
Sep 03, 2020 $9.25 $9.52 $9.05 $9.38 2 170 055
Sep 02, 2020 $8.90 $9.39 $8.80 $9.38 2 208 445
Sep 01, 2020 $9.35 $9.41 $8.46 $8.91 2 239 858
Aug 31, 2020 $9.28 $9.78 $9.24 $9.29 3 123 540
Aug 28, 2020 $8.56 $9.20 $8.51 $9.12 2 366 712
Aug 27, 2020 $8.63 $8.74 $8.33 $8.56 1 646 621
Aug 26, 2020 $8.22 $8.84 $8.16 $8.63 2 554 320
Aug 25, 2020 $7.94 $8.34 $7.80 $8.21 1 536 212
Aug 24, 2020 $8.01 $8.10 $7.68 $7.88 1 588 458
Aug 21, 2020 $8.15 $8.18 $7.66 $7.91 1 735 055
Aug 20, 2020 $7.60 $8.19 $7.56 $8.13 1 741 487
Aug 19, 2020 $7.55 $7.92 $7.42 $7.71 1 726 283
Aug 18, 2020 $7.20 $7.69 $7.08 $7.50 2 132 144
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT